{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:02:49Z","timestamp":1788458569108,"version":"build-2803163510"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T00:00:00Z","timestamp":1542067200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2018.00575","type":"journal-article","created":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T03:25:22Z","timestamp":1542079522000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Patterns of Management of Patients With Dual Disorder (Psychosis) in Italy: A Survey of Psychiatrists and Other Physicians Focusing on Clinical Practice"],"prefix":"10.3389","volume":"9","author":[{"given":"Massimo","family":"Clerici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"de Bartolomeis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"De Filippis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Ducci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Icro","family":"Maremmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Martinotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Schifano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.psychres.2014.12.006","article-title":"Comorbid substance use disorders in schizophrenia: a latent class approach","volume":"225","author":"Kerner","year":"2015","journal-title":"Psychiatry Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1111\/add.14145","article-title":"The associations between psychotic experiences and substance use and substance use disorders: findings from the World Health Organization World Mental Health surveys","volume":"113","author":"Degenhardt","year":"2018","journal-title":"Addiction"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1001\/jama.1990.03450190043026","article-title":"Comorbidity of mental disorders with alcohol and other drug abuse","volume":"264","author":"Regier","year":"1990","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s00127-015-1025-2","article-title":"Substance use disorders in schizophrenia, bipolar disorder, and depressive illness: a registry-based study","volume":"50","author":"Nesvag","year":"2015","journal-title":"Soc Psychiatry Psychiatr Epidemiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/YCO.0b013e3282f51266","article-title":"The effect of cannabis on the brain: can it cause brain anomalies that lead to increased risk for schizophrenia?","volume":"21","author":"Delisi","year":"2008","journal-title":"Curr Opin Psychiatry"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1093\/schbul\/sbm011","article-title":"Substance use and abuse in first-episode psychosis: prevalence before and after early intervention","volume":"33","author":"Archie","year":"2007","journal-title":"Schizophr Bull."},{"key":"B7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.pnpbp.2013.07.020","article-title":"Cannabis abuse in adolescence and the risk of psychosis: a brief review of the preclinical evidence","volume":"52","author":"Rubino","year":"2014","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B8","doi-asserted-by":"publisher","first-page":"683","DOI":"10.3238\/arztebl.2015.0683","article-title":"Trans-sector integrated treatment in psychosis and addiction","volume":"112","author":"Gouzoulis-Mayfrank","year":"2015","journal-title":"Dtsch Arztebl Int."},{"key":"B9","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.psychres.2014.01.026","article-title":"Clinical differences between cocaine-induced psychotic disorder and psychotic symptoms in cocaine-dependent patients","volume":"216","author":"Roncero","year":"2014","journal-title":"Psychiatry Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.eurpsy.2004.06.031","article-title":"Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence","volume":"19","author":"Lambert","year":"2004","journal-title":"Eur Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0924-9338(11)71710-2","article-title":"Country differences in patient characteristics and treatment in schizophrenia: data from a physician-based survey in Europe","volume":"26","author":"Papageorgiou","year":"2011","journal-title":"Eur Psychiatry"},{"key":"B12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/08897077.2014.960551","article-title":"Comorbid addiction and major mental illness in Europe: a narrative review","volume":"36","author":"Carra","year":"2015","journal-title":"Subst Abus."},{"key":"B13","first-page":"411","article-title":"Pilot studies","volume":"17","author":"Connelly","year":"2008","journal-title":"Medsurg Nurs."},{"key":"B14","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/nur.20247","article-title":"Considerations in determining sample size for pilot studies","volume":"31","author":"Hertzog","year":"2008","journal-title":"Res Nurs Health"},{"key":"B15","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3389\/fnins.2015.00297","article-title":"Metabolic issues in patients affected by schizophrenia: clinical characteristics and medical management","volume":"9","author":"Ventriglio","year":"2015","journal-title":"Front Neurosci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1007\/s12035-015-9110-9","article-title":"Clinically combating reward deficiency syndrome (RDS) with dopamine agonist therapy as a paradigm shift: dopamine for dinner?","volume":"52","author":"Blum","year":"2015","journal-title":"Mol Neurobiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/00952990701877078","article-title":"Temperament and character inventory dimensions and anhedonia in detoxified substance-dependent subjects","volume":"34","author":"Martinotti","year":"2008","journal-title":"Am J Drug Alcohol Abus."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1126\/science.38504","article-title":"Antipsychotic drug action in schizophrenic patients: effect on cortical dopamine metabolism after long-term treatment","volume":"205","author":"Bacopoulos","year":"1979","journal-title":"Science"},{"key":"B19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0014-2999(91)90214-B","article-title":"Profound depression of mesolimbic dopamine release after morphine withdrawal in dependent rats","volume":"193","author":"Acquas","year":"1991","journal-title":"Eur J Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/ajmg.b.30080","article-title":"Relationship between dopaminergic neurotransmission, alcoholism, and reward deficiency syndrome","author":"Bowirrat","year":"2005","journal-title":"Am J Med Genet B Neuropsychiatr Genet."},{"key":"B21","doi-asserted-by":"publisher","first-page":"12700","DOI":"10.1523\/JNEUROSCI.3371-07.2007","article-title":"Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement","volume":"27","author":"Volkow","year":"2007","journal-title":"J Neurosci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1038\/npp.2012.41","article-title":"Dopamine-related deficit in reward learning after catecholamine depletion in unmedicated, remitted subjects with bulimia nervosa","volume":"37","author":"Grob","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.17756\/jrds.2015-016","article-title":"Dopamine in the brain: hypothesizing surfeit or deficit links to reward and addiction","volume":"1","author":"Blum","year":"2015","journal-title":"J Reward Defic Syndr."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1708\/1228.13610","article-title":"Negative dimensions in Psychiatry","volume":"48","author":"Rovai","year":"2013","journal-title":"Riv Psichiatr."},{"key":"B25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0022-3956(69)90007-7","article-title":"Physiological parameters of morphine dependence in man, early abstinence, protracted abstinence","volume":"7","author":"Martin","year":"1969","journal-title":"J Psychiatr Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0165-0327(97)00059-1","article-title":"Subthreshold depressions: clinical and polysomnographic validation of dysthymic, residual and masked forms","volume":"45","author":"Akiskal","year":"1997","journal-title":"J Affect Disord."},{"key":"B27","first-page":"5","article-title":"Understanding the pathogenesis of drug addiction in order to implement a correct pharmacological intervention","volume":"5","author":"Maremmani","year":"2003","journal-title":"Heroin Addiction Rel Clinical Prob."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e0201371","DOI":"10.1371\/journal.pone.0201371","article-title":"Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy","volume":"13","author":"Ostuzzi","year":"2018","journal-title":"PLoS ONE"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.2147\/NDT.S171002","article-title":"Head-to-head comparison of 1-year aripiprazole long-acting injectable (LAI) versus paliperidone LAI in comorbid psychosis and substance use disorder: impact on clinical status, substance craving, and quality of life","volume":"14","author":"Cuomo","year":"2018","journal-title":"Neuropsychiatr Dis Treat."},{"key":"B30","doi-asserted-by":"publisher","first-page":"E1935","DOI":"10.3390\/ijms17111935","article-title":"Clinical decision-making in the treatment of schizophrenia: focus on long-acting injectable antipsychotics","volume":"17","author":"Samalin","year":"2016","journal-title":"Int J Mol Sci."},{"key":"B31","first-page":"234","article-title":"Treatment patterns of schizophrenia based on the data from seven Central and Eastern European Countries","volume":"28","author":"Szkultecka-Debek","year":"2016","journal-title":"Psychiatr Danub."},{"key":"B32","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1017\/S204579601600010X","article-title":"Quality of care indicators for schizophrenia: determinants of observed variations among Italian Departments of Mental Health","volume":"26","author":"Fantini","year":"2017","journal-title":"Epidemiol Psychiatr Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2147\/NDT.S98711","article-title":"Attitudes toward metabolic adverse events among patients with schizophrenia in Japan","volume":"12","author":"Sugawara","year":"2016","journal-title":"Neuropsychiatr Dis Treat"},{"key":"B34","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/eip.12085","article-title":"What is the current status of training and practice of early intervention in psychiatry? results from a survey in 35 countries","volume":"9","author":"Fiorillo","year":"2015","journal-title":"Early Interv Psychiatry"},{"key":"B35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/104012371402600104","article-title":"Barriers to utilizing long-acting injectable antipsychotic medications","volume":"26","author":"Getzen","year":"2014","journal-title":"Ann Clin Psychiatry"},{"key":"B36","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1176\/appi.ajp.2016.16050503","article-title":"Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology","volume":"174","author":"Howes","year":"2017","journal-title":"Am J Psychiatry"},{"key":"B37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pnpbp.2015.08.010","article-title":"Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones","volume":"65","author":"Iasevoli","year":"2016","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B38","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.psychres.2013.06.042","article-title":"Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses","volume":"210","author":"De Bartolomeis","year":"2013","journal-title":"Psychiatry Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.pnpbp.2017.09.002","article-title":"Treatment resistant schizophrenia and neurological soft signs may converge on the same pathology: Evidence from explanatory analysis on clinical, psychopathological, and cognitive variables","volume":"81","author":"De Bartolomeis","year":"2018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.pnpbp.2013.06.008","article-title":"Can antipsychotic treatment contribute to drug addiction in schizophrenia?","volume":"52","author":"Samaha","year":"2014","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2018.00575\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T01:34:40Z","timestamp":1775266480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2018.00575\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,13]]},"references-count":40,"alternative-id":["10.3389\/fpsyt.2018.00575"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2018.00575","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,13]]},"article-number":"575"}}